Gaps in current knowledge and priorities for future research in dry eye

Cornea

Volumn 36, Issue 12, 2017, Pages 1584-1591

  Saldanha, Ian J ^a   Dickersin, Kay ^b   Hutfless, Susan T ^c   Akpek, Esen K ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Clinical trials; Dry eye; Research priorities; Systematic reviews

Indexed keywords

AGENTS ACTING ON THE EYE; ARTIFICIAL TEAR; CYCLOSPORINE; OMEGA 3 FATTY ACID;

ARTICLE; CLINICAL RESEARCH; DELPHI STUDY; DRY EYE; EVIDENCE BASED PRACTICE; HUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; ATTITUDE TO HEALTH; DIETARY SUPPLEMENT; MEDICAL RESEARCH; OPHTHALMOLOGY; PROCEDURES;

BIOMEDICAL RESEARCH; CYCLOSPORINE; DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUBRICANT EYE DROPS; OPHTHALMOLOGY;

EID: 85045556814     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000001350     Document Type: Article

References (25)

1. Gayton GL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405-412.
2. 2007 report of the International Dry Eye WorkShop (DEWS). Ocul Surf. 2007;5:65-204.
3. Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol. 2010;149:405-415.
4. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: A decision tree analysis. Cornea. 2011;30:379-387.
5. Behrens A, Doyle JJ, Stern l, et al. Dysfunctional tear syndrome: A Delphi approach to treatment recommendations. Cornea. 2006;25: 900-907.
6. Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015; 13:118-132.
7. Robinson KA, Saldanha IJ, McKoy NA. Development of a framework to identify research gaps from systematic reviews. J Clin Epidemiol. 2011; 64:1325-1330.
8. Li T, Ervin AM, Scherer R, et al. Setting priorities for comparative effectiveness research: A case study using primary open- Angle glaucoma. Ophthalmology. 2010;117:1937-1945.
9. Li T, Vedula SS, Scherer R, et al. What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities. Ann Intern Med. 2012;156:367-377.
10. Saldanha IJ, Wilson LM, Bennett WL, et al. Development and pilot test of a process to identify research needs from a systematic review. J Clin Epidemiol. 2013;66:538-545.
11. Robinson KA, Saldanha IJ, McKoy NA. Identification of research gaps from evidence-based guidelines: A pilot study in cystic fibrosis. Int J Technol Assess Health Care. 2011;27:247-252.
12. Yu T, Li T, Lee KJ, et al. Setting priorities for comparative effectiveness research on management of primary angle closure: A survey of Asia- Pacific clinicians. J Glaucoma. 2015;24:348-355.
13. Smith N, Mitton C, Peacock S, et al. Identifying research priorities for health care priority setting: A collaborative effort between managers and researchers. BMC Health Serv Res. 2009;9:165.
14. Le JT, Hutfless S, Li T, et al. Setting priorities for diabetic retinopathy clinical research and identifying evidence gaps. Ophthalmol Retina. 2017;1:94-102.
15. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern- Guidelines. Dry Eye Syndrome. San Francisco, CA: American Academy of Ophthalmology; 2013. Available at: www.aao.org/ppp. Accessed June 27, 2017.
16. Tear Film and Ocular Surface Society. Mission. Available at: http://www.tearfilm.org/mission.php. Accessed June 27, 2017.
17. Ervin AM, Wojciechowski R, Schein O. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev. 2010:CD006775.
18. Pan Q, Angelina A, Zambrano A, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2013:CD009327.
19. Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. 2016: CD009729.
20. Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjögren syndrome: A systematic review. JAMA. 2010;304:452-460.
21. Sacchetti M, Mantelli F, Lambiase A, et al. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. Br J Ophthalmol. 2014;98:1016-1022.
22. Wu D, Chen WQ, Li R, et al. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: A systematic review of randomized clinical trials. Cornea. 2015;34:644-650.
23. Zhu W, Wu Y, Li G, et al. Efficacy of polyunsaturated fatty acids for dry eye syndrome: A meta- Analysis of randomized controlled trials. Nutr Rev. 2014;72:662-671.
24. Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013; 158:200-207.
25. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:698-702.